Corrigendum to “Beneficial effects of 5-fluorouracil and heparin-based portal infusion chemotherapy combined with mitomycin C and cisplatin after curative resection of pancreatic cancer” [Pancreatology 10 (2010) 250–258](S1424390316312637) (10.1016/j.pan.2016.12.014))

Koichi Aiura, Shin Takahashi, Junichi Matsui, Masakazu Ueda, Yuukou Kitagawa

Research output: Contribution to journalComment/debate

Abstract

The authors regret that the following errors have occurred. The number of patients who died from cancer and other diseases in each group (control group, PI2W group, and PI4W group) are described in Table 3. However, death from diseases other than cancer was omitted as a form of mortality during the analysis of the data for overall survival. Subsequently, the data in Fig. 3 and 4 do not represent that of overall survival, and the correct description would be “disease-specific survival.” Therefore, re-analysis of overall survival was performed using the same method in the original article, based on the definition of overall survival, and Fig. 3 and 4 for Overall Survival should be replaced with the new versions of the figures below. These changes, however, do not impact the scientific conclusion and value of the study. Corrections to be made: This figure should be replaced. The correct figure is below.

Original languageEnglish
Pages (from-to)151-152
Number of pages2
JournalPancreatology
Volume17
Issue number2
DOIs
Publication statusPublished - 2017 Mar 1

Fingerprint

Mitomycin
Pancreatic Neoplasms
Fluorouracil
Cisplatin
Heparin
Drug Therapy
Survival
Survival Analysis
Neoplasms
Emotions
corrigendum
Control Groups
Mortality

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

@article{481d534841ea4fdfac7cfae2a16b0b73,
title = "Corrigendum to “Beneficial effects of 5-fluorouracil and heparin-based portal infusion chemotherapy combined with mitomycin C and cisplatin after curative resection of pancreatic cancer” [Pancreatology 10 (2010) 250–258](S1424390316312637) (10.1016/j.pan.2016.12.014))",
abstract = "The authors regret that the following errors have occurred. The number of patients who died from cancer and other diseases in each group (control group, PI2W group, and PI4W group) are described in Table 3. However, death from diseases other than cancer was omitted as a form of mortality during the analysis of the data for overall survival. Subsequently, the data in Fig. 3 and 4 do not represent that of overall survival, and the correct description would be “disease-specific survival.” Therefore, re-analysis of overall survival was performed using the same method in the original article, based on the definition of overall survival, and Fig. 3 and 4 for Overall Survival should be replaced with the new versions of the figures below. These changes, however, do not impact the scientific conclusion and value of the study. Corrections to be made: This figure should be replaced. The correct figure is below.",
author = "Koichi Aiura and Shin Takahashi and Junichi Matsui and Masakazu Ueda and Yuukou Kitagawa",
year = "2017",
month = "3",
day = "1",
doi = "10.1016/j.pan.2016.12.014",
language = "English",
volume = "17",
pages = "151--152",
journal = "Pancreatology",
issn = "1424-3903",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Corrigendum to “Beneficial effects of 5-fluorouracil and heparin-based portal infusion chemotherapy combined with mitomycin C and cisplatin after curative resection of pancreatic cancer” [Pancreatology 10 (2010) 250–258](S1424390316312637) (10.1016/j.pan.2016.12.014))

AU - Aiura, Koichi

AU - Takahashi, Shin

AU - Matsui, Junichi

AU - Ueda, Masakazu

AU - Kitagawa, Yuukou

PY - 2017/3/1

Y1 - 2017/3/1

N2 - The authors regret that the following errors have occurred. The number of patients who died from cancer and other diseases in each group (control group, PI2W group, and PI4W group) are described in Table 3. However, death from diseases other than cancer was omitted as a form of mortality during the analysis of the data for overall survival. Subsequently, the data in Fig. 3 and 4 do not represent that of overall survival, and the correct description would be “disease-specific survival.” Therefore, re-analysis of overall survival was performed using the same method in the original article, based on the definition of overall survival, and Fig. 3 and 4 for Overall Survival should be replaced with the new versions of the figures below. These changes, however, do not impact the scientific conclusion and value of the study. Corrections to be made: This figure should be replaced. The correct figure is below.

AB - The authors regret that the following errors have occurred. The number of patients who died from cancer and other diseases in each group (control group, PI2W group, and PI4W group) are described in Table 3. However, death from diseases other than cancer was omitted as a form of mortality during the analysis of the data for overall survival. Subsequently, the data in Fig. 3 and 4 do not represent that of overall survival, and the correct description would be “disease-specific survival.” Therefore, re-analysis of overall survival was performed using the same method in the original article, based on the definition of overall survival, and Fig. 3 and 4 for Overall Survival should be replaced with the new versions of the figures below. These changes, however, do not impact the scientific conclusion and value of the study. Corrections to be made: This figure should be replaced. The correct figure is below.

UR - http://www.scopus.com/inward/record.url?scp=85009454674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009454674&partnerID=8YFLogxK

U2 - 10.1016/j.pan.2016.12.014

DO - 10.1016/j.pan.2016.12.014

M3 - Comment/debate

AN - SCOPUS:85009454674

VL - 17

SP - 151

EP - 152

JO - Pancreatology

JF - Pancreatology

SN - 1424-3903

IS - 2

ER -